At Aceragen, we address rare, orphan diseases that typically have no available treatments, and strive to develop novel therapies to positively impact the lives of patients and families.
Santi’s story illustrates how symptoms of Farber disease were missed at first but became impossible to ignore as the condition rapidly progressed.
Receive email updates about ASAH1-related conditions and Aceragen.